CellCentric's Series C Round

CellCentric raised a round of funding on June 25, 2013.

CellCentric is a clinical stage biotechnology company focused on the development of the novel drug CCS1477 for prostate (CRPC) and other cancers.…

Articles about CellCentric's Series C Round: